compound glp 1 ending FDA Phasing Out Compounded GLP-1 Medications — Prescription Network FDA sets tirzepatide compounding deadlines

Childhood obesity is associated with higher blood pressure and increased cardiovascular risk in adulthood

My patients are buying unstandardized and contaminated research-grade vials of who-knows-what off the internet and injecting it into themselves

Broadening horizons: The role of ferroptosis in cancer

What I Got Wrong About Menopause and Metabolism, and What I Recommend Now GLP-1s and Hormone Therapy: A New Era in Menopause Metabolic Care If you had told me ten years ago that Id be using GLP-1 medications and hormone therapy together to help my patients manage belly fat and metabolic dysfunction, I probably would have raised an eyebrow